Acceletronics Announces Installation of 15 TheraView Electronic Portal Imaging Devices for IGRT Treatment Verification

Acceletronics Inc. announced that it has recently completed the installation of 15 TheraView Electronic Portal Imaging Devices (EPID) over the past six months to 11 cancer treatment centers in the U.S. The TheraView EPID is an image-guided radiotherapy (IGRT) cancer treatment verification system designed by Dutch manufacturer Cablon Medical BV.
The TheraView system is designed for the precise needs of radiation therapy and provides clinicians with an extensive scope of mega-voltage portal imaging and quality assurance features for daily IGRT verification. TheraView Target Check with automated treatment beam shape verification and patient position verification software reportedly offers the precision and control clinicians need for both conventional, image-guided (IGRT) and intensity-modulated radiation therapy (IMRT).